ASSET PURCHASE AGREEMENT by and among BRECKENRIDGE PHARMACEUTICAL, INC. and PERNIX THERAPEUTICS HOLDINGS, INC. and CYPRESS PHARMACEUTICALS, INC.Asset Purchase Agreement • August 9th, 2013 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (as amended from time to time, the “Agreement”) is made as of this 5nd day of August, 2013 (the “Agreement Date”), by and among Breckenridge Pharmaceutical, Inc., a Florida corporation (“Purchaser”), and Pernix Therapeutics Holding, Inc., a Maryland company (“Pernix”) and Cypress Pharmaceuticals, Inc., a Mississippi company (“Cypress”) (Pernix and Cypress being referred to collectively as “Seller”). Purchaser, Pernix and Cypress are each referred to individually as a “Party” and together as the “Parties.”
